financetom
Business
financetom
/
Business
/
Music labels sue AI companies Suno, Udio for US copyright infringement
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Music labels sue AI companies Suno, Udio for US copyright infringement
Jun 24, 2024 9:02 AM

(Reuters) -Major record labels Sony Music, Universal Music Group and Warner Records sued artificial intelligence companies Suno and Udio on Monday, accusing them of committing mass copyright infringement by using the labels' recordings to train music-generating AI systems.

The companies copied music without permission to teach their systems to create music that will "directly compete with, cheapen, and ultimately drown out" human artists' work, according to federal lawsuits filed against Udio in New York and Suno in Massachusetts.

Representatives for Suno and Udio did not immediately respond to requests for comment on the complaints.

The complaints said Suno and Udio users have been able to recreate elements of songs including The Temptations' "My Girl," Mariah Carey's "All I Want for Christmas Is You" and James Brown's "I Got You (I Feel Good)," and could generate vocals that are "indistinguishable" from musicians such as Michael Jackson, Bruce Springsteen and ABBA.

The labels asked the courts to award statutory damages of up to $150,000 per song the defendants allegedly copied.

The lawsuits are the first to target music-generating AI following several cases brought by authors, news outlets and others over the alleged misuse of their work to train text-based AI models powering chatbots like OpenAI's ChatGPT. AI companies have argued that their systems make fair use of copyrighted material.

Cambridge, Massachusetts-based Suno and New York-based Udio have raised millions in funding this year for their AI systems, which create music in response to user text prompts.

The labels' complaints said the companies have been "deliberately evasive" about the material they used to train their technology, and that revealing it would "admit willful copyright infringement on an almost unimaginable scale."

"Unlicensed services like Suno and Udio that claim it's 'fair' to copy an artist's life's work and exploit it for their own profit without consent or pay set back the promise of genuinely innovative AI for us all," Mitch Glazier, CEO of the Recording Industry Association of America, said in a statement.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Adobe forecasts downbeat quarterly earnings on cautious tech spending
Adobe forecasts downbeat quarterly earnings on cautious tech spending
Sep 12, 2024
Sept 12 (Reuters) - Photoshop maker Adobe forecast fourth-quarter earnings below analysts' estimates on Thursday, signaling stiff competition and soft demand for its AI-integrated editing tools amid challenging economic conditions. Shares of the company fell 9.2% in extended trading. High interest rates and a tough economy have led enterprises and individuals to focus on cutting costs, putting pressure on Adobe's...
Mission Produce Insider Sold Shares Worth $685,447, According to a Recent SEC Filing
Mission Produce Insider Sold Shares Worth $685,447, According to a Recent SEC Filing
Sep 12, 2024
05:13 PM EDT, 09/12/2024 (MT Newswires) -- Luis A Gonzalez, 10% Owner, Director, on September 12, 2024, sold 51,615 shares in Mission Produce ( AVO ) for $685,447. Following the Form 4 filing with the SEC, Gonzalez has control over a total of 8,278,037 shares of the company, with 32,423 shares held directly and 8,245,614 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1802974/000182588524000024/xslF345X05/wk-form4_1726175264.xml...
BioNexus Gene Lab, Chenzhen Rongguang Health Group Partner to Expand Cancer Screening
BioNexus Gene Lab, Chenzhen Rongguang Health Group Partner to Expand Cancer Screening
Sep 12, 2024
01:42 PM EDT, 09/12/2024 (MT Newswires) -- BioNexus Gene Lab ( BGLC ) plans to partner with Chenzhen Rongguang Health Group to expand cancer screening and diagnostic tools in Southeast Asia and China. The collaboration includes research and development of exosome therapy and regenerative medicine, BioNexus said Thursday in a statement. Price: 0.49, Change: +0.14, Percent Change: +38.78 ...
--RH Guides For FY 2024 Revenue Growth of 5%-7%; Sees Q3 Revenue Growth of 7%-9%
--RH Guides For FY 2024 Revenue Growth of 5%-7%; Sees Q3 Revenue Growth of 7%-9%
Sep 12, 2024
04:11 PM EDT, 09/12/2024 (MT Newswires) -- Price: 299.00, Change: +42.23, Percent Change: +16.45 ...
Copyright 2023-2025 - www.financetom.com All Rights Reserved